Why the study?
Does the 6-minute walk test elicit different metabolic stress and aerobic capacity compared to symptom-limited incremental maximal exercise testing in patients with pulmonary arterial hypertension?
Does the 6-minute walk test elicit different metabolic stress and aerobic capacity compared to symptom-limited incremental maximal exercise testing in patients with pulmonary arterial hypertension?
Answers are grounded in this paper and cite their sources.
Patients with pulmonary arterial hypertension exercise at a higher aerobic capacity but lower metabolic stress during the 6-minute walk test compared to a maximal cardiopulmonary exercise test.
The 6-min walk test (6MWT) is commonly used to evaluate exercise capacity in patients with pulmonary arterial hypertension (PAH). However, little is known about the corresponding metabolic stress as measured by cardiopulmonary exercise testing. The present study, therefore, measured ventilatory variables and heart rate during the 6MWT and symptom-limited incremental maximal exercise testing in 20 patients with PAH. The distance walked in 6 min was 450+/-22 m (mean+/-se). During the 6MWT, ventilation, O2 consumption, CO2 production and heart rate increased during the first 3-4 min, and then remained stable. As compared with the maximum values measured during the cardiopulmonary exercise test, O2 consumption tended to be higher (14.2+/-0.6 versus 12.9+/-0.7 mL.kg-1.min-1), while maximum ventilation (46+/-3 versus 57+/-4 L.min-1), respiratory quotient (0.90+/-0.02 versus 1.15+/-0.02) and heart rate (119+/-4 versus 135+/-4 beats.min-1) remained lower. In conclusion, patients with pulmonary arterial hypertension exercise at higher aerobic capacity and lower metabolic stress during the 6MWT than during a cardiopulmonary exercise test.
No takes yet. Share an insight, caveat, or question.
Gaël Deboeck (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: